This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Bioassay Remove Gene Editing Remove Production Related Topics
Reagent Bioinformatics In-Vivo Protein Gene RNA DNA Containment Gene Therapy Clinical Development More Related Topics >
article thumbnail

At-home Self-testing: A Giant Leap Towards Transformation in Diagnostic Sector

Roots Analysis

JANUARY 16, 2023

In the health industry, digitization has evolved over time with numerous advances to ensure that everyone has equitable access to health products and medical specialists. Gene Editing beyond CRISPR Market, 2022-2035. Cell and Gene Therapy Bioassay Services Market, 2021-2030. Our Social Media Platform.

Bioassay 52
Bioassay Gene Editing Marketing Gene Therapy 52
article thumbnail

Reflecting on PEGS Europe 2023 

Drug Discovery World

NOVEMBER 30, 2023

It was presented by Lei Shi, PhD, Senior Vice President, R&D, Biointron Biological, titled: ‘Accelerating early discovery through HTP and high-speed antibody production’. From a product perspective, RedShiftBio had the Aurora protein analyser with them in Lisbon this year.

Antibody 59
Antibody Protein Engineer In-Vivo 59
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024